INTRODUCTION
============

Aminoacyl tRNA synthetases perform a critical function in conversion of the genetic code into amino acids by covalently attaching the correct amino acid to specific cognate tRNAs ([@gkr1223-B1],[@gkr1223-B2]). These enzymes are divided into two structural classes, each arising from a common ancestor ([@gkr1223-B3],[@gkr1223-B4]), and catalyze aminoacyl-tRNA formation by a two-step pathway: (i) an activated aminoacyl adenylate is first formed from ATP and the cognate amino acid; (ii) the amino acid is transferred to its cognate tRNA with release of AMP. Each synthetase nearly perfectly selects the correct tRNA among 20--22 different isoacceptor tRNA families ([@gkr1223-B5]) as well as the correct amino acid substrate; in some cases, this is achieved via the use of hydrolytic editing mechanisms to clear misactivated amino acid and/or misacylated tRNA ([@gkr1223-B3],[@gkr1223-B4]). It is of particular interest that tRNA^Gln^ and tRNA^Asn^ are aminoacylated by distinct mechanisms in different kingdoms. For example, whereas Gln-tRNA^Gln^ is formed in the canonical manner in the eukaryotic cytoplasm, all archaea, many bacteria and eukaryotic organelles possess an alternative two-step pathway. In this route, a non-discriminating GluRS first misaminoacylates tRNA^Gln^; next, the Glu-tRNA^Gln^ is converted to Gln-tRNA^Gln^ by a tRNA-dependent amidotransferase belonging to either the GatCAB family (bacteria and some archaea), or the GatDE family (archaea only) ([@gkr1223-B6; @gkr1223-B7; @gkr1223-B8]). Thus, glutaminyl-tRNA synthetase (GlnRS) is primarily a eukaryotic enzyme. Synthesis of cysteinyl-tRNA^Cys^ in methanogens and highly related archaea provides another example of a two-step pathway to cognate aminoacyl-tRNA, although the phylogenetic distribution of this pathway is much more limited ([@gkr1223-B9]).

Eukaryotic tRNA synthetases are distinctly more complex than their prokaryotic homologs because they have progressively acquired and retained additional domains throughout evolution ([@gkr1223-B1],[@gkr1223-B2]). It is perplexing why tRNA synthetases, unlike other eukaryotic proteins, have been subject to massive progressive additions over the course of evolution ([@gkr1223-B2]). While some appended domains are shared among synthetase families and are similar to domains in other proteins implicated in either nucleic acid binding or protein--protein interactions ([@gkr1223-B1]), at least eight domains are uniquely associated with a single synthetase family, and neither their structures nor their roles are generally understood ([@gkr1223-B2]). An exception is the CTD of human CysRS, which is known to enhance anticodon discrimination at the expense of the aminoacylation rate, acting as a quality control step ([@gkr1223-B10]). This report focuses on the NTD of GlnRS, which is itself unique because GlnRS likely originated in eukaryotes, evolving directly from a progenitor eukaryotic non-discriminating GluRS ([@gkr1223-B11],[@gkr1223-B12]). Like other eukaryotic GlnRS species, *Saccharomyces cerevisiae* Gln4 contains both a highly conserved C-terminal domain (CTD) with all of the known features of class I synthetases, as well as a less conserved appended N-terminal domain (NTD) with no obvious sequence homology to any known protein domain.

The origin and function of the NTD in GlnRS are of particular interest. Most eukaryotic GlnRS proteins have an appended NTD, whereas the bacterial GlnRS proteins do not, although the bacterial proteins were almost certainly acquired by horizontal transfer from eukaryotes. *Saccharomyces cerevisiae* GlnRS contains both a 595-amino acid CTD that contains the signature elements of a type I synthetase ([@gkr1223-B4],[@gkr1223-B13; @gkr1223-B14; @gkr1223-B15]), and suffices for both catalytic function and yeast viability ([@gkr1223-B16],[@gkr1223-B17]), and a 224-amino acid NTD that is uniquely associated with GlnRS in many eukaryotes ([@gkr1223-B2]). Although both *Escherichia coli* and *Deinococcus radiodurans* GlnRS proteins share extensive identity with the conserved *S. cerevisiae* GlnRS CTD, *E. coli* GlnRS entirely lacks an NTD ([@gkr1223-B13]) and *D. radiodurans* GlnRS has an unrelated domain appended to the C-terminus of the conserved domain ([@gkr1223-B14]). Two observations imply that the *S. cerevisiae* NTD contributes to synthetase function: the NTD alone exhibits a non-specific RNA binding activity ([@gkr1223-B18]), and the addition of the NTD to *Ec*GlnRS results in a chimeric protein that can replace the native yeast gene ([@gkr1223-B19]). However, the precise role of the NTD in eukaryotic GlnRS function is unknown.

MATERIALS AND METHODS
=====================

Genetic analysis of *gln4* mutants
----------------------------------

To construct a strain (MEM70) of genotype *gln4-Δ::kan^R^* \[*CEN URA3 GLN4*\], a *CEN GLN4* plasmid was transformed into yeast strain BY4741, and then the *gln4-ΔKan* allele was introduced by transformation, using PCR primers HWI P239 and HWI P234 ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)) to amplify the fragment from the appropriate *GLN4*/ *gln4-ΔKan* heterozygous diploid (Open Biosystems ID 22424). To construct strains bearing an integrated copy of either *GLN4* or *gln4-Δ2--210*, we used an integrating cassette ([@gkr1223-B20]) that carries *MET15* flanked by sequences homologous to *ADE2*, into which we inserted *GLN4* or the *gln4(211--809)* allele (constructed with a synthetic fragment made by Geneart). Plasmids were then digested with Stu I to release the integrating cassette and transformed into MEM70, and transformants were screened for Ade^−^, and plated on FOA to select for removal of the *CEN URA3 GLN4* plasmid, generating the desired *gln4-Δ::kan^R^ ade2*^−^::*GLN4*::*MET15* (MEM133) and *gln4-Δ::kan^R^ ade2*^−^::*gln4(211--809)*::*MET15* (MEM141) strains. To test for growth phenotypes, MEM133 and MEM141 were transformed with a \[*CEN LEU2 GLN4*\] or a control \[*CEN LEU2*\] vector, grown overnight in SD-Leu media ([@gkr1223-B21]), diluted to OD~600~ of 1 and 2 µl of 10-fold serial dilutions were spotted onto plates containing either YPD or YP glycerol and incubated at the indicated temperatures for 1--7 days with similarly spotted control parent strains that were grown in YPD media. Oligonucleotides, yeast strains and plasmids used in these studies are reported in [Supplementary Tables S1--S3](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1).

Protein expression and purification
-----------------------------------

To express high levels of *GLN4* and its derivatives in yeast, ORFs were cloned under P*~GAL1~* control into the previously described 2 µ *URA3* LIC vectors BG2483 or BG2663, in which ORFs are expressed with their C termini fused to a complex tag containing a 3C protease site, followed by an HA epitope, His~6~, and the ZZ domain of protein A ([@gkr1223-B22]), and expressed in yeast strain BCY123 ([@gkr1223-B23]). Gln4(1--187) was expressed in yeast strain EJG1473, which was grown in media containing selenomethionine and Ado-Methionine as described ([@gkr1223-B24]). Expressed proteins were purified by affinity purification on IgG sepharose, removal of GST-3C protease, concentration of samples and sizing on SuperdexHiLoad 1660 (GE Healthcare 17--1069, 10 mm× 300 mm bed dimension), as described ([@gkr1223-B22]).

tRNA purification and EMSA binding assay
----------------------------------------

To obtain native yeast tRNA^Gln(CUG)^, we cloned the *tQ(CUG)M* gene into the *leu2-d URA3* vector pYEX4T ([@gkr1223-B25]), transformed the plasmid into BY4741, grew transformants in SD-Ura media overnight, followed by overnight growth in SD-Leu-Ura media. We then prepared low molecular weight RNA, purified the tRNA^Gln^ with biotinylated oligonucleotides oligo HWI P257 ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)), and performed HPLC analysis of modified nucleotides as described ([@gkr1223-B26]). The ratio of modified to unmodified nucleotides was similar to that in strains with tRNA^Gln^ on a lower copy plasmid.

tRNA binding was measured, as described ([@gkr1223-B27]) in reaction mixtures containing Gln4 or its buffer, 2.4 nM 5′-\[^32^P\]-labeled tRNA, in buffer containing 28 mM HEPES (pH 7.5), 80 mM NaCl, 5 mM MgCl~2~, 0.5 mM DTT, 2.5 mM spermidine, 50 µg/ml BSA, 20 µM EDTA, 200 µg/ml polyA, 4.6 mM *Tris*-Cl (pH 7.5), 1 mM β-mercaptoethanol and 10% glycerol. Reactions were incubated for 20 min on ice and loaded onto prerun 5% polyacrylamide gels containing 50 mM *Tris*-borate, pH 8.3, 1 mM EDTA, 5 mM MgCl~2~ and 5% glycerol, and run at 4°C in the same buffer without glycerol.

*In vitro* synthesis of tRNA transcripts
----------------------------------------

Duplex DNA templates for *in vitro* transcription of yeast tRNA^Gln^ were synthesized from two single-stranded oligodeoxynucleotides containing a complementary overlap duplex region, as described ([@gkr1223-B28]). The two 3′-terminal deoxynucleotides on the non-coding strand incorporated 2′-*O*-methyl sugars (mU and mG in the sequences), to improve the fidelity of transcription termination by T7 RNA polymerase. Milligram quantities of each tRNA were transcribed with the Del(172--173) variant of T7 RNA polymerase, as described ([@gkr1223-B28],[@gkr1223-B29]), and purified by denaturing polyacrylamide gel electrophoresis. tRNA was stored at 200 µM in 10 mM Tris (pH 8.0), 1 mM EDTA (TE buffer).

Steady state methods
--------------------

tRNA^Gln^ transcripts were ^32^P-labeled at the 3′-terminal internucleotide linkage using the exchange reaction of tRNA nucleotidyltransferase ([@gkr1223-B30; @gkr1223-B31; @gkr1223-B32]), and purified again by gel electrophoresis. Steady state kinetics of tRNA aminoacylation reactions were performed in a buffer consisting of 50 mM Tris-HCl (pH 7.5), 10 mM MgCl~2~ and 10 mM β-mercaptoethanol. tRNA was first refolded by heating to 85°C in TE buffer for 3 min, followed by addition of MgCl~2~ to 10 mM and slow-cooling to ambient temperature. Two microliters of aliquots from the reactions were added to 5 µl of a quenching solution containing 400 mM sodium acetate (pH 5.2) and 0.1% SDS, followed by addition of 3--5 ml of 0.01--0.1 mg/ml P1 nuclease (Fluka) to digest the tRNA to 5′-phosphorylated nucleosides. The digestion products were spotted on PEI-cellulose thin layer chromatography (TLC) plates and developed in a solution containing 100 mM ammonium acetate and 5% acetic acid. Raw data were quantified by phosphorimaging analysis, and corrected intensities were analyzed to obtain initial velocities. K~M~ and V~max~ were then obtained by Michaelis--Menten analysis. ATP (5 mM) was used in all reactions; saturation was confirmed for both FL-GlnRS and the NTD variant. The glutamine concentrations used to determine *K*~M~^(tRNA)^ for FL-GlnRS and Gln4(187--809) were 10 and 60 mM, respectively; saturation was verified in each case. tRNA concentrations used were 20 nM--3 µM for FL-GlnRS and 500 nM--20 µM for Gln4(187--809). To determine *K*~M~ for glutamine, the tRNA concentrations used were 1 µM for FL-GlnRS and 15 µM for Gln4(187--809). Enzyme concentrations were maintained at least 20-fold below tRNA concentrations for all experiments to ensure multiple-turnover conditions.

Crystallization and structure determination
-------------------------------------------

Initial crystallization conditions were identified using a high-throughput microbatch-under-oil method ([@gkr1223-B33]). Crystals appeared after a 6-week incubation at 22°C in conditions containing 0.2 µl protein solution (8.9 mg/ml protein in 100 mM NaCl, 5% (v/v) glycerol, 2 mM DTT, 0.025% (w/v) NaN~3~, 20 mM HEPES buffer, pH 7.5) and 0.2 µl of precipitant solution (100 mM KCl, 100 mM Tris-HCl, pH 8 and 20% (w/v) PEG 4000). Crystals were extracted directly from the well and were determined suitable for X-ray data collection from initial screening. No further optimization took place.

Remote MAD data collection was carried out at 100 K on beamline 11--1 of the Stanford Synchrotron Radiation Lightsource (SSRL) ([@gkr1223-B34]) with a MAR 325 CCD detector. To minimize radiation effects, the data collection protocol was designed with Best ([@gkr1223-B35]) automated within the WebIce analysis package ([@gkr1223-B36]). Integration, reduction and scaling took place with XDS ([@gkr1223-B37]). The structure was solved with Phenix ([@gkr1223-B38]). Using the remote wavelength data set the structure was refined through an iterative process using Phenix with manual model building with Coot ([@gkr1223-B39]). Validation was carried out with Molprobity ([@gkr1223-B40]). The structure was deposited as PDB ID 3TL4. Experimental and refinement details are given in [Supplementary Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1). Surface charge was calculated assuming vacuum electrostatics using PyMol.

The sequences of several appended NTDs from GlnRS sequences of other organisms, listed in [Table 2](#gkr1223-T2){ref-type="table"}, were threaded to the Gln4(1--187) structure using SwissModel ([@gkr1223-B41]). As a control the reversed sequence was also threaded. From the models a *Z*-score was calculated using Prosa2003 ([@gkr1223-B42]) with a 20-residue moving window. The typical combined, pairwise and surface *Z*-scores for native proteins are (−6 to −12), (−3 to −7.5) and (−3 to −8), respectively. Alignments were performed using the 'fit' function of PyMOL. Due to low sequence homology, only carbon alpha atoms were included in the alignment. Loops were removed prior to RMS deviation calculation.

RESULTS
=======

Removal of the NTD impairs Gln4 function *in vivo* and *in vitro*
-----------------------------------------------------------------

To determine if the NTD is important for the essential function of Gln4, we compared the growth of yeast strains expressing either full length *GLN4* or *gln4* lacking the NTD \[*gln4*(211--809)\] integrated into the chromosome under control of its own promoter, as the sole source of *Sc*GlnRS. Growth of the *gln4*(211--809) mutant is impaired at 14°C and 19°C, but not at 30°C, on both YPD and YP glycerol media, and, as expected, this phenotype is complemented by full length *GLN4* on a single copy plasmid but not by an empty vector ([Figure 1](#gkr1223-F1){ref-type="fig"}A). In addition, the *gln4*(211--809) mutant is much more sensitive than wild-type to [l]{.smallcaps}-methionine sulfoximine, a highly specific inhibitor of glutamine synthase ([@gkr1223-B43]), which results in reduced concentrations of intracellular glutamine ([Figure 1](#gkr1223-F1){ref-type="fig"}B). These observations demonstrate that the NTD plays an important role in the function of the native yeast enzyme *in vivo*. Figure 1.Deletion of the N-terminal domain of *GLN4* impairs function. (**A**) Mutants bearing a *gln4* mutation in which amino acids 2--210 are deleted are defective in growth at low temperature on YP media containing glucose or glycerol as a carbon source. Serial dilutions of strains with either wild-type *GLN4* or *gln4(*211--809) (marked *gln4-ΔN*\*) integrated at the *ade2* locus in the *gln4-ΔKanR* mutant were grown as indicated. Indicated strains carry CEN plasmids either with or without *GLN4*. (**B**) Mutants bearing a *gln4* mutation in which amino acids 2--210 are deleted are sensitive to the glutamine synthase inhibitor [l]{.smallcaps}-methionine sulfoximine (MSX).

Steady-state kinetic parameters were measured to directly assess the effects of the NTD on tRNA^Gln^ aminoacylation. Substantial differences between full length Gln4 and Gln4(187--809) were found. For the wild-type enzyme, similar K~M~*^tRNA^* (0.14 µM versus 0.19 µM) and *k*~cat~ (1.7 s^−1^ versus 1.4 s^−1^) were measured for affinity-purified native tRNA^Gln^ and an unmodified transcript, suggesting that post-transcriptional modifications do not have significant effects in this system. Using unmodified tRNA^Gln(CUG)^ as substrate, we then found that Gln4(187--809) exhibits a 30-fold increase in *K*~M~*^tRNA^* (from 0.2 µM to 5.8 µM), and a 5.4-fold increase in K~M~*^Gln^* (from 1.7 mM to 9.3 mM) although the *k*~cat~ values are similar (1.4 s^−1^ versus 1.7 s^−1^) ([Table 1](#gkr1223-T1){ref-type="table"}). We infer that the NTD influences the complementarity of both the tRNA and glutamine binding sites for their respective substrates, as also suggested by the sensitivity of the Gln4(211--809) mutant to [l-]{.smallcaps}methionine sulfoximide. Table 1.Comparison of steady state kinetic parameters for Gln4 and Gln4 variants*k*~cat~ (s^−1^)*K*~M~^tRNA^ (µM)*k*~cat~/*K*~M~^tRNA^ (M^−1^·s^−1^)*K*~M~^Gln^ (mM)*k*~cat~/*K*~M~^Gln^ (M^−1^·s^−1^)FL-Gln41.4 ± 0.20.19 ± 0.047.6 × 10^6^1.7 ± 0.28.5 × 10^2^Gln4 (187--809)1.7 ± 0.35.85 ± 0.522.9 × 10^5^9.3 ± 0.31.8 × 10^2^PVG-GlnRS2.8 ± 0.61.55 ± 0.511.8 × 10^6^NANAFL-Gln4 + native tRNA1.7 ± 0.10.14 ± 0.071.2 × 10^7^NANA

Since the kinetic analysis suggested a role for the NTD in tRNA^Gln^ binding, we developed an EMSA assay to directly measure binding. We find that yeast Gln4 binds tightly and specifically to fully modified tRNA^Gln(CUG)^ purified from *S. cerevisiae*, with ∼25 nM Gln4 required for 50% binding ([Figure 2](#gkr1223-F2){ref-type="fig"}A and B, see [Figure 5](#gkr1223-F5){ref-type="fig"}) while \>800 nM Gln4 is required to bind comparably to tRNA^Phe^ ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)). Remarkably, Gln4(187--809) binds only very weakly at 27 µM, 1000-fold above the apparent *K*~D~ of wild-type Gln4 ([Figure 2](#gkr1223-F2){ref-type="fig"}A and B), and other Gln4 variants Gln4(211--809) and Gln4(216--809) do not detectably bind tRNA^Gln(CUG)^ ([Figure 2](#gkr1223-F2){ref-type="fig"}A). Furthermore, there was no improvement in binding of Gln4(187--809) in the presence of other Gln4 substrates including glutamine, ATP or the non-hydrolyzable ATP analog AMPPNP ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)). Figure 2.The N-terminal domain of Gln4 is required for specific binding to native tRNA^Gln(CUG)^. (**A**) Gln4 variant proteins deleted for different amounts of the NTD exhibit reduced tRNA^Gln(CUG)^ binding. (**B)** Gln4(187--809) protein exhibits detectable binding to tRNA^Gln(CUG)^ at high concentrations.

The Gln4 NTD is structurally similar to two subdomains in the amidotransferase that distinguish tRNA^Gln^ from tRNA^Glu^
------------------------------------------------------------------------------------------------------------------------

To further discern the function of the NTD, we solved the structure of the isolated NTD, which behaves as a discrete unit to confer function when fused to the *E. coli* GlnRS ([@gkr1223-B19]). We purified three NTD variants ending at amino acids 187, which spans the region of extensive identity between the NTD of GlnRS from multiple species (see below), 215 and 228, which covers the entire region without extensive homology to *E. coli* GlnRS. We obtained crystals of Gln4(1--187) that diffracted to 2.3 Å, and solved the structure of a selenomethionine derivative purified from a yeast *sam1-Δ sam2-Δ* mutant ([@gkr1223-B24]) ([Supplementary Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)).

Gln4(1--187) consists of two alpha helical domains, the first from residues 1--111 containing a seven-helix bundle, and the second from residues 119--187 containing a four-helix bundle, which are connected by a seven residue G~112~VG~114~IGIT linker ([Figure 3](#gkr1223-F3){ref-type="fig"}A). One face of each domain is positively charged across the length of the domain, which might facilitate interactions with the negatively charged tRNA and provide the basis for the non-specific RNA binding activity of this domain ([@gkr1223-B18]) ([Figure 3](#gkr1223-F3){ref-type="fig"}B). Figure 3.Structure of Gln4(1--187) with comparisons to domains in *S. aureus* GatB (PDB ID: 3IP4). (**A**) Crystallographic structure of Gln4 residues 1--187 in cartoon representation. The proposed hinge region (Gly~112~Val~113~Gly~114~) is highlighted together with the likely interacting residue Trp~160~, and shown in stick representation. (**B**) Surface electrostatic model of Gln4 residues 1--187, shown with two orientations rotated by 90° relative to each other, with positively charged residues colored blue. (**C** and **D**) Structural alignment of helical and tail domains of Gln4 NTD and *S. aureus* GatB (PDB ID: 3IP4) ([@gkr1223-B45]). (C) The crystal structure of Gln4(1--110) (red) is superposed to the helical domain of GatB(295--406) (cyan). (D) The crystal structure of Gln4(119--178) (red) is superposed on the tail domain of GatB(414--475) (cyan).

Although the NTD lacks sequence homology to any available structure, a DALI search ([@gkr1223-B44]) of the NTD and the individual domains revealed substantial structural homology to the helical and tail domains of the GatB subunit of GatCAB, the glutamyl-tRNA admidotransferase, from *Staphylococcus aureus* (PDB ID: 3IP4) ([@gkr1223-B45]) and *Thermotoga maritima* (PDB ID: 3AL0) ([@gkr1223-B46]) ([Figure 3](#gkr1223-F3){ref-type="fig"}C and D; [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)). The seven-helix bundle seen in the NTD yields an RMS deviation of 3.75 Å using carbon alpha atoms in the alpha helices of *S. aureus* GatB and 4.01 Å when compared with *T. maritima*. However, a five residue insertion between helix 4 and helix 5 appears to shift the orientation of the remaining three helices of *S. aureus* GatB. When aligning these three helices separately, an RMS deviation of 1.89 Å is observed. The four-helix bundle of the C-terminal subdomain of the NTD has an RMS deviation of only 1.64 Å compared with the *S. aureus* GatB tail domain, and 1.80 Å compared with the *T. maritima* GatB tail domain. Since the GatB helical and tail domains make specific and non-specific contacts with tRNA^Gln^ ([@gkr1223-B46]), we infer that the Gln4 NTD has similar biochemical function. Furthermore, it is likely that GlnRS NTDs from other eukaryotes adopt a similar structure, based on threading of these sequences to the Gln4(1--187) structure ([@gkr1223-B47]) ([Table 2](#gkr1223-T2){ref-type="table"}). Table 2.Comparison of sequences threaded to the N-term Gln(1--187) structureNameSpeciesResidues*Z*-scoreCombinedPairSurfaceN-term*Saccharomyces cerevisiae*186−11.23−7.98−8.71N-term reversed*Saccharomyces cerevisiae*186−0.30−1.560.55P13188*Saccharomyces cerevisiae*186−11.28−7.99−8.75q9y7y8*Schizosaccharomyces pombe*190−6.02−0.79−7.00q9y105*Drosophila melanogaster*188−3.991.11−5.62q62431*Mus musculus*183−8.42−6.44−5.92p47897*Homo sapiens*185−6.55−3.69−5.20q3mhh4*Bos taurus*185−6.62−3.84−5.22p52780*Lupinus luteus*188−7.02−1.73−6.90p14325*Dictyostelium discoideum*185−7.98−4.06−6.92GatB*Thermotog maritima*177−10.43−6.42−8.91

The linker between the NTD subdomains is conserved and functionally important
-----------------------------------------------------------------------------

Three observations suggest that the linker that connects the two domains in Gln4 plays a crucial role in the tRNA binding function of this domain. First, the helical and tail domains of GatB are also connected by a linker, which appears to function as a flexible hinge that closes upon tRNA binding, based on differences in the orientation of the domains in the tRNA-bound (*T. maritima)* and tRNA-free (*S. aureus)* structures ([@gkr1223-B45],[@gkr1223-B46]). In this regard, we note that the domains in the Gln4 NTD are oriented at an angle between that of the *T. maritima* tRNA-bound GatB and the *S. aureus* tRNA-free GatB ([Figure 4](#gkr1223-F4){ref-type="fig"}A). Second, although the linker sequences in GlnRS differ from the sequences in GatB, the linker sequences in GlnRS are among the most highly conserved amino acids in the Gln4 NTD family ([Figure 4](#gkr1223-F4){ref-type="fig"}B). In a comparison of highly divergent eukaryotes, although neither the length nor the sequence of the N-terminal domain is highly conserved, three of the seven amino acids in the linker region G~112~V~113~G~114~ are nearly 100% conserved ([Figure 4](#gkr1223-F4){ref-type="fig"}B and C). Furthermore, G~112~ appears to interact with W~160~, 1 of the 10 other highly conserved residues in the NTD; the alpha carbon of G112 is in van der Waals contact with C9 of W160 ([Figures 3](#gkr1223-F3){ref-type="fig"}A and [4](#gkr1223-F4){ref-type="fig"}C and D). Third, G~114~ is predicted to be a hinge residue, acting as a flexible connector of the two domains, based on an elastic network analysis with the program HingeProt ([@gkr1223-B48]). Figure 4.The linker between the two domains in Gln4(1--187) likely behaves as a hinge, is highly conserved and is important for tRNA binding. (**A**) Structure of Gln4(1--187) (red) superposed on *TM*GatB (light gray) and *SA*GatB (dark gray) by alignment of the tail domains. (**B**) Conservation of GlnRS NTD sequences, red-≥90%; blue-≥70%, with arrow at Gln4~187~., aligned using Multialin ([@gkr1223-B49]). (**C**) Conserved residues are highlighted on Gln4(1--187) according to the color code in B with the NTD backbone shown in light grey. (**D**) Close contacts between W160 of the Gln4 NTD and other residues.

Since the G~112~V~113~G~114~ residues of the linker are highly conserved, and since hinges frequently mediate conformational changes upon ligand binding ([@gkr1223-B50]), we considered it likely that mutations in the linker region would impair function. Thus, we purified variant proteins in which G~112~V~113~G~114~ was replaced with AAA and with PVG and in which W~160~ was replaced with F or A, and measured tRNA^Gln(CUG)^ binding. Although the variant proteins all bind tRNA^Gln(CUG)^, as measured by reduced mobility of the tRNA, all of the mutant proteins exhibit defects in binding ([Figure 5](#gkr1223-F5){ref-type="fig"}A and B). Three variants (Gln4-A~112~A~113~A~114~, Gln4-G~112~P, Gln4-W~160~A) fail to form stable complexes with tRNA^Gln(CUG)^, as judged by lack of comigration of the complexed tRNA with that formed by wild-type Gln4, and all four variant proteins exhibit an apparently reduced affinity for tRNA^Gln(CUG)^, requiring 4--12 times more protein than the wild-type to bind comparable amounts of tRNA ([Figure 5](#gkr1223-F5){ref-type="fig"}C). Moreover, the Gln4-G~112~P variant exhibits a 10-fold increase in the K~M~*^tRNA^* (from 0.19 µM to 1.6 µM) as well as a slight increase in *k*~cat~ (1.4 s^−1^ versus 2.8 s^−1^) ([Table 1](#gkr1223-T1){ref-type="table"}). Thus, we conclude that the linker region is important for binding, and speculate that it acts as a hinge facilitating closure between the helical and tail domains upon tRNA binding. Figure 5.Mutations in conserved amino acids in the putative hinge of the NTD affect the interaction of Gln4 with native tRNA^Gln(CUG)^. (**A** and **B**) EMSA wild-type and mutant Gln4 proteins (23--2017 nM). (**C**) Binding as a function of Gln4 protein concentration.

DISCUSSION
==========

The observations that the NTD of *S. cerevisiae* GlnRS bears a substantial structural resemblance to two domains of the bacterial GatB amidotransferase that distinguish tRNA^Gln^ from tRNA^Glu^, and that the NTD also participates in tRNA^Gln^ binding, imply that there is a connection between the indirect pathways for formation of Gln-tRNA^Gln^ in bacteria and archaea, and the direct pathway that evolved in eukaryotes. Since it is thought that tRNA^Gln^ was present in the last universal common ancestor, it has been puzzling that aminoacylation of this tRNA is achieved by different routes in each of the three kingdoms. Sheppard and Soll proposed that both GatCAB and GatDE were present prior to the split between archaea and bacteria ([@gkr1223-B51]), while the specific GlnRS evolved in eukaryotes. We propose that the tRNA^Gln^ recognition domain from an amidotransferase was most likely conscripted as an NTD to a progenitor non-discriminating GluRS, and thus played an integral part in the development of the eukaryotic GlnRS family. In particular, evolution of GlnRS from an early non-discriminating GluRS required selectivity determinants in favor of tRNA^Gln^ to evolve, while negative determinants against tRNA^Glu^ would also appear. The proximity of the NTD to the tRNA-synthetase core domain suggests that eukaryotes may have exploited the NTD domain to provide subtle structural discrimination between tRNA^Gln^ and tRNA^Glu^ prior to the appearance of discriminatory residues in other synthetase domains conserved between eukaryotes and bacteria.

In support of this, we find evidence that the NTD of GlnRS likely existed in the common eukaryotic ancestor, based on comparative genomic reconstruction of the Gln4 family ([@gkr1223-B52]). Thus, GlnRS proteins from highly diverse, free living eukaryotes, spanning lineages from the ancient JEH and POD clades through more recent clades (including Plantae, Amoebozoans and Opisthokonts) share a recognizably homologous, but diverse, NTD of 210--259 amino acids ([Figure 4](#gkr1223-F4){ref-type="fig"}B and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)). Curiously, we and others ([@gkr1223-B53]) have also found that the appended domain is absent in some eukaryotes, including parasitic protozoa such as *Trypanosoma brucei* and *Leishmania major*, as well as the *Eurotiomycetidae*, *Trichocomaceae* fungi. There also appears to be a correlation between the presence of the appended domain and the use of U~73~ as the discriminator base ([Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkr1223/DC1)). Thus, although an appended domain is not required to construct a specific GlnRS, such a domain was likely a part of the specific GlnRS in the eukaryotic common ancestor and may have played a crucial role in the development of a specific GlnRS.

Our findings also point to a parallel between the appended domains in eukaryotic GlnRS proteins and in GlnRS in the bacterium *D. radiodurans* ([@gkr1223-B14]), even though the eukaryotic domains are located on the N terminus, upstream of the conserved core, while the appended domain of the *D. radiodurans* GlnRS is on the C terminus, downstream of the conserved core. Although the Gln4 NTD and the *D. radiodurans* GlnRS CTD have no significant sequence similarity ([@gkr1223-B14]), and are at opposite termini, it is likely that the *D. radiodurans* GlnRS CTD, like the Gln4 NTD, is structurally related to GatB, because the CTD has weak sequence homology with regions of GatB, and cross reacts with GatB antibody ([@gkr1223-B14]).
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